Avenue Therapeutics, Inc. (ATXI)
NASDAQ: ATXI · Real-Time Price · USD
1.770
-0.030 (-1.67%)
At close: Dec 20, 2024, 4:00 PM
1.710
-0.060 (-3.39%)
After-hours: Dec 20, 2024, 5:38 PM EST
Avenue Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Net Income | -9.47 | -10.38 | -3.55 | -3.73 | -5.15 | -25.91 | |
Asset Writedown & Restructuring Costs | - | 3 | - | - | - | - | |
Stock-Based Compensation | 1.02 | 0.91 | 0.65 | 0.44 | 0.71 | 1.84 | |
Other Operating Activities | -1.6 | -2.69 | -5.1 | - | - | - | |
Change in Accounts Receivable | 0.01 | - | 0.09 | -0.09 | - | - | |
Change in Accounts Payable | -0.78 | -0.36 | 0.35 | -0.38 | -0.23 | -3.23 | |
Change in Other Net Operating Assets | 0.23 | 0.07 | -0.03 | 0.01 | 0.06 | 1.04 | |
Operating Cash Flow | -10.59 | -9.45 | -7.6 | -3.75 | -4.61 | -26.26 | |
Sale (Purchase) of Intangibles | - | -3 | - | - | - | - | |
Other Investing Activities | - | - | - | - | -1 | - | |
Investing Cash Flow | - | -3 | - | - | -1 | - | |
Issuance of Common Stock | 14.16 | 7.53 | 11.65 | 5.04 | - | 35 | |
Repurchase of Common Stock | - | - | -1.1 | - | - | - | |
Other Financing Activities | -1.14 | - | - | -0.66 | - | -2.67 | |
Financing Cash Flow | 13.02 | 7.53 | 10.54 | 4.38 | - | 32.33 | |
Net Cash Flow | 2.44 | -4.93 | 2.95 | 0.63 | -5.61 | 6.07 | |
Free Cash Flow | -10.59 | -9.45 | -7.6 | -3.75 | -4.61 | -26.26 | |
Free Cash Flow Per Share | -11.88 | -66.92 | -260.72 | -248.20 | -314.41 | -1879.00 | |
Levered Free Cash Flow | -10.1 | -13.49 | -1.25 | -2.36 | -3.72 | -15.93 | |
Unlevered Free Cash Flow | -10.1 | -13.49 | -1.25 | -2.36 | -3.72 | -15.93 | |
Change in Net Working Capital | 3.74 | 2.31 | -3.13 | 0.46 | 1.17 | 1.36 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.